SPECIALIZING IN THE ACQUISITION AND
OPERATION OF INTERNATIONAL CANNABIS ASSETS

Vertically Integrated on
an International Scale

Cultivated Globally

About ICC

ICC International Cannabis, through its subsidiaries, has operating assets and is developing a world class platform. Most importantly, this platform will be used for cultivation, extraction, formulation and distribution across the globe. As a result, ICC has operations in the United Kingdom, Denmark, Poland, Switzerland, Macedonia, Bulgaria, Greece, Italy, Portugal, Malta, Colombia, Australia, South Africa and Lesotho.

Europe

Denmark

Licences for cannabis cultivation and manufacturing.

Portugal

Cultivation, extraction, formulation and export of CBD products.

 

Poland

Licences for the extraction and manufacturing of CBD products.

Greece

Interest in CBD production licences. In addition, a conditional pre-approval for a medical cannabis licence.

Italy

Candidate for one of seven medical Cannabis cultivation licences, CBD cultivation and distribution.

United Kingdom

One of three companies to successfully import medical cannabis.

Switzerland

Cannabis cultivation and extraction.

Malta

Import/export. Further, licences for processing for finished-dose medical cannabis.

South America

Colombia

Licences to cultivate, produce and distribute. In addition, licences to store, and export cannabis and cannabis derivatives.

Africa

Lesotho

Licences to cultivate, produce and distribute. In addition, licences to store, and export cannabis and cannabis products.

Oceania

Australia

Late stage medical cannabis cultivation applicant. In addition, a Northern Territory sponsorship.

India

India

Cannabinoid sole comprehensive research and development as well as cannabis import and export.

35,000

KG

EU-GMP MEDICAL CANNABIS IMPORT AGREEMENT OVER A THREE YEAR TERM WITH WAYLAND GROUP

2,400

KG

OF CBD ISOLATE PRODUCED IN 2018

OVER

2,700

CANNABIS STRAINS

80,000

LOCATIONS

RETAIL OUTLETS, PHARMACIES AND STORES REPRESENTING 80,000 LOCATIONS

19

LICENCES

FOR CULTIVATION, SPANNING FOUR CONTINENTS

50,000

KG

OF CBD ISOLATE IN 2019

740K

KG

OF FORECASTED DRIED CANNABIS PRODUCTION FROM OUTDOOR CANNABIS CULTIVATION

Partnerships

Continued Investment Into Innovation: Cannabinoids Biosynthesis

Fundamentally changing the industry by genetically engineering synthetic cannabinoid profiles identical to those found in nature. By 2020, mass production of bio-synthetic CBD/THC will allow ICC to reach new heights

European Licensing Agreement

ICC International Cannabis Corp. has signed a licensing agreement with Authentic Brands Group (ABG), to market and distribute cannabidiol-derived health and wellness products throughout Europe under the Marilyn Monroe, Elvis Presley, Greg Norman, Tretorn, Aeropostale and Frederick’s of Hollywood brands.

BuyWell Care Ecosystem

International Cannabis, Evergreen Pacific and Cannops will collaborate to introduce transformative extended healthcare coverages. Subsequently, this will include cannabinoid therapeutic coverage, to the European marketplace.

Flagship Strategic Investment

Auxly and ICC have entered into a partnership. Above all, this partnership will add value to the international platforms of both Companies.

News

INTERNATIONAL CANNABIS TO PURCHASE UP TO 100,000,000 GRAMS OF PREMIUM DRIED CANNABIS FLOWER FROM AGRAFLORA

VANCOUVER, British Columbia, May 22, 2019 – ICC International Cannabis Corp. (CSE: WRLD.U)(FWB: 8K51)(OTC: WLDCF) (“ICC” or “International Cannabis”) is pleased to announce that the Company has entered into a commercial rights and off-take agreement with AgraFlora Organics International Inc. (“AgraFlora”) (CSE: AGRA) (Frankfurt: PU31) (OTCPK: PUFXF), whereby ICC may purchase up to 100,000,000 grams of premium dried cannabis flower from AgraFlora’s Delta Greenhouse Complex cultivation operations, over a five year term.

read more

INTERNATIONAL CANNABIS APPLAUDS “BfARM” CONFIRMATION OF WAYLAND’S AWARD FOR GERMAN CANNABIS PRODUCTION

VANCOUVER, British Columbia, May 21, 2019 – ICC International Cannabis Corp. (CSE: WRLD.U)(FWB: 8K51)(OTC: WLDCF) (“ICC” or “International Cannabis”) applauds today’s announcement by Wayland Group Corp. (“Wayland”) that its joint venture DEMECAN GmbH (“DEMECAN”), of which Wayland holds 50% with an option to increase to 60% has been awarded three lots of domestic cannabis production in Germany by the Federal Institute for Drugs and Medical Devices (“BfArM”), after the withdrawal of a competitor’s complaint following an oral court hearing.

read more

TRANSATLANTIC SPORTS TEAM PARTNERS WITH ICC AND ORGANIC FLOWER TO FORMULATE AND DISTRIBUTE CBD PERFORMANCE ATHLETICS SKUs

VANCOUVER, British Columbia, May 13, 2019 – ICC International Cannabis Corp. (CSE: WRLD.U)(FWB: 8K51)(OTC: WLDCF) (“ICC” or “International Cannabis” or the “Company”) and Organic Flower Investments Group Inc. (CSE: SOW)(FWB: 2K6)(OTC: QILFF) (“Organic Flower”) are excited to announce the Companies have entered into definitive agreements with the Toronto Wolfpack RLFC (“Toronto Wolfpack” or “TWP”) and HowlBrands to manufacture and distribute a suite of athlete-focused, cannabidiol (“CBD”) performance products.

read more

Blog

Cannabis Strains: What’s in a name?

The past and future of naming marijuana strains “What’s in a name? that which we call a rose…By any other name would smell as sweet.” The sheer delight of merging grade 10 English and the revelry of Shakespeare, with cannabis naming trends of today is inexplicable....

read more